Patents by Inventor Claudine Madoulet

Claudine Madoulet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
    Publication number: 20110064795
    Abstract: The invention relates to an immunogenic composition which comprises, firstly, a carrier and, secondly, as antigenic structure, conjugates comprising all or part of the amino acid sequences of at least one peptide derived from an extracellular loop of the P-170 protein, each peptide being combined with several molecules of fatty acid containing a carbon chain of between C12 and C24 so as to allow, under suitable administration conditions, the induction of anti-P-170 antibodies.
    Type: Application
    Filed: August 30, 2010
    Publication date: March 17, 2011
    Applicant: AC IMMUNE SA
    Inventors: Pierre-Francois Tosi, Claudine Madoulet, Claude Yves Nicolau, David T. Hickman
  • Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
    Publication number: 20050244419
    Abstract: The invention relates to an immunogenic composition which comprises, firstly, a carrier and, secondly, as antigenic structure, conjugates comprising all or part of the amino acid sequences of at least one peptide derived from an extracellular loop of the P-170 protein, each peptide being combined with several molecules of fatty acid containing a carbon chain of between C12 and C24 so as to allow, under suitable administration conditions, the induction of anti-P-170 antibodies. The invention relates to said composition for defining means for treating multidrug resistances.
    Type: Application
    Filed: January 21, 2005
    Publication date: November 3, 2005
    Inventors: Pierre-Francois Tosi, Claudine Madoulet, Claude Nicolau, David Hickman
  • Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
    Publication number: 20050175615
    Abstract: The invention relates to an immunogenic composition which comprises, firstly, a carrier and, secondly, as antigenic structure, conjugates comprising all or part of the amino acid sequences of at least one peptide derived from an extracellular loop of the P-170 protein, each peptide being combined with several molecules of fatty acid containing a carbon chain of between C12 and C24 so as to allow, under suitable administration conditions, the induction of anti-P-170 antibodies. The invention relates to said composition for defining means for treating multidrug resistances.
    Type: Application
    Filed: July 30, 2004
    Publication date: August 11, 2005
    Inventors: Pierre-Francois Tosi, Claudine Madoulet, Claude Nicolau, David Hickman